Novembre
2011
Cruise Medicine & International Symposia on Maritime Health:
From Odessa 2011 to Brest 2013
Pr
Eilif Dahl,
MD, MHA, PhD,
University
of
Bergen
/ Norwegian Centre for Maritime Medicine,
Bergen,
Norway
After the 11th
International Symposium on Maritime Health (11ISMH) in
Odessa
this year, I’m left with the impression that the organizers had
not really grasped the fact that cruise medicine is an important
part of maritime health. One session on ‘Cruise Medicine’ was
announced.
Six papers were to be presented,
but the only confirmation the authors received prior to the
meeting was a program draft circulated shortly before the
symposium started. At that point two of the authors had made
other plans. When the final program was distributed at
registration in
Odessa,
the cruise medicine presentations had been reduced from 15 to 10
minutes each and the cruise session had been moved to a time
when one of the two remaining presenters should already be on
his return flight home. In the end the session was moved
forward, but without proper announcements and to a double-booked
small auditorium. Despite all these problems and shortcomings,
the turn-out was surprisingly good, - with eager audience
participation on subjects like guidelines for asymptomatic,
stable HIV-positive crew members; handling and costs of
varicella cases and outbreaks among crew; a case series on
life-saving blood transfusions aboard; results from fleet-wide
use of a standardized ‘first responder bag’ for emergencies
outside the cruise ship infirmaries; and outcome after treatment
of cardiac arrest on cruise ships.
Recommendations to put automatic external defibrillators (AEDs)
on ships
without medical
professionals aboard are highly controversial and triggered
heated discussions on several occasions during 11ISMH. In
contrast, there is no doubt that AEDs should be part of the
standard equipment on densely populated cruise ships with a
highly trained medical staff on 24/7 call. Preliminary data from
Royal Caribbean Cruise Line ships showed survival rates that
exceed those from out-of-hospital cardiac arrests in all major
US
cities. Hence, cardiac arrest is likely to be riskier at home
than on a well-equipped and well-staffed cruise ship.
Within the maritime medical
community it has been argued that cruise medicine concentrates
on passengers, and therefore is of less interest to the maritime
health of crew. Clearly, the passengers’ expectations and
demands are the primary impetus to advance medical care on
cruise ships. However, the passengers are only on board for a
very limited time, whereas the ship’s doctors are the primary
physicians for the crew for many months at the time. The
majority of patients seen in most cruise ship infirmaries are
crew members. Hence, they certainly benefit from all the medical
resources available to the passengers. Furthermore, after
experiencing cruise medical care the crew members will bring
their expectations of higher quality medical service to other
ships and thus push for improved maritime health
internationally.
According to John le Carré, a desk
is a dangerous place from where to view the world. -‘And the
sea’, one could add. Cruise ships employ a steadily growing
number. In
Odessa,
medical representatives from the two largest cruise corporations
were in attendance, representing more than 100.0000 seafarers.
Some of the cruise vessels have more than 2.400 crew members
aboard. Every ship carries physicians and nurses. They are on
board to observe conditions related to health and medicine and
to intervene when irregularities occur. This means that every
cruise ship can be viewed as a potential medical laboratory, and
thus the experience of the medical staff should be valuable to
all involved with maritime health.
Both the
US
and the
European
Centers
for Disease Control and Prevention (CDC & ECDC) are land-based
organisations that have turned cruise ships into
de facto
epidemiological laboratories. The knowledge gained through
reports from the medical staff aboard cruise ships about
prevention and management of outbreaks aboard have also proven
valuable for handling of infectious diseases ashore.
Even the amputated cruise ship
session in
Odessa
demonstrated that the cruise industry is a front runner
regarding maritime health, and all involved with this subject
will gain from medical information gathered by cruise companies.
Likewise, the cruise industry will benefit from contact with the
rest of the maritime health community. There are numerous issues
of mutual interest.
France
is a major builder of cruise ships. Therefore, the
Brest
organizers of the 12th International Symposium on
Maritime Health in 2013 hopefully realize the importance of
cruise medicine for general maritime health and will take this
into consideration when they arrange the conference program:
§
They should actively encourage cruise representatives to
participate at 12ISMH
§
Enough time should be allotted to cruise presentations and
discussions
§
Cruise reports of general interest should be presented in
plenary sessions, and
§
Sessions on subjects
of mutual interest should be carefully scheduled to avoid
collisions
The road to success is always under construction; - see you all
in Brest 2013!
-----------------------------------------------------------------------
Eilif Dahl,
MD, MHA, PhD
Consultant, Pediatric Surgery, Division of Surgery,
Rikshospitalet, Oslo University Hospital, 0027 Oslo, &
Professor, University of Bergen, Norwegian Centre for
Maritime Medicine, Haukeland University Hospital,
5021 Bergen. Norway
cell phone +47 959 21 759